New Insights into the Bioenergetic and Immunomodulatory Properties of Phospholipases A2 from Bothrops diporus Venom Christopher.Koski@bruker.com New Insights into the Bioenergetic and Immunomodulatory Properties of Phospholipases A2 from Bothrops diporus Venom Read More »
Integrative Analysis of Multi-omic Pathways Predict Cancer-Affected Lobes in Lung Cancer Christopher.Koski@bruker.com Integrative Analysis of Multi-omic Pathways Predict Cancer-Affected Lobes in Lung Cancer Read More »
LRRC15-CAR T cells for the treatment of osteosarcoma Christopher.Koski@bruker.com LRRC15-CAR T cells for the treatment of osteosarcoma Read More »
Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models Christopher.Koski@bruker.com Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models Read More »
ADP-dependent platelet activation is required for thrombus formation in mice exposed to simulated flight conditions Christopher.Koski@bruker.com ADP-dependent platelet activation is required for thrombus formation in mice exposed to simulated flight conditions Read More »
IL-12-armed oncolytic HSV-2 enhances CAR T cell efficacy against pancreatic cancer in xenografted models Christopher.Koski@bruker.com IL-12-armed oncolytic HSV-2 enhances CAR T cell efficacy against pancreatic cancer in xenografted models Read More »
Glycolysis maintains effector function of lung Th17 TRM cells in precision cut lung slices Christopher.Koski@bruker.com Glycolysis maintains effector function of lung Th17 TRM cells in precision cut lung slices Read More »
Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models Christopher.Koski@bruker.com Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models Read More »
A Phase II Study of Sitravatinib Combined With Tislelizumab Plus Docetaxel for Acquired Resistance to PD-(L)1 in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Christopher.Koski@bruker.com A Phase II Study of Sitravatinib Combined With Tislelizumab Plus Docetaxel for Acquired Resistance to PD-(L)1 in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Read More »
Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function | Cancer Immunology Research | American Association for Cancer Research Christopher.Koski@bruker.com Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function | Cancer Immunology Research | American Association for Cancer Research Read More »
